Literature DB >> 34743180

Neonatal sepsis definitions from randomised clinical trials.

Rían Hayes1, Jack Hartnett1, Gergana Semova1, Cian Murray1, Katherine Murphy1, Leah Carroll1, Helena Plapp1, Louise Hession1, Jonathan O'Toole1, Danielle McCollum1, Edna Roche1, Elinor Jenkins1, David Mockler2, Tim Hurley1,3, Matthew McGovern1,3, John Allen1,3,4, Judith Meehan1,4, Frans B Plötz5,6, Tobias Strunk7,8, Willem P de Boode9, Richard Polin10, James L Wynn11,12, Marina Degtyareva13, Helmut Küster14, Jan Janota15,16, Eric Giannoni17, Luregn J Schlapbach18,19,20, Fleur M Keij21, Irwin K M Reiss21, Joseph Bliss22, Joyce M Koenig23, Mark A Turner24, Christopher Gale25, Eleanor J Molloy26,27,28,29,30.   

Abstract

INTRODUCTION: Neonatal sepsis is a leading cause of infant mortality worldwide with non-specific and varied presentation. We aimed to catalogue the current definitions of neonatal sepsis in published randomised controlled trials (RCTs).
METHOD: A systematic search of the Embase and Cochrane databases was performed for RCTs which explicitly stated a definition for neonatal sepsis. Definitions were sub-divided into five primary criteria for infection (culture, laboratory findings, clinical signs, radiological evidence and risk factors) and stratified by qualifiers (early/late-onset and likelihood of sepsis).
RESULTS: Of 668 papers screened, 80 RCTs were included and 128 individual definitions identified. The single most common definition was neonatal sepsis defined by blood culture alone (n = 35), followed by culture and clinical signs (n = 29), and then laboratory tests/clinical signs (n = 25). Blood culture featured in 83 definitions, laboratory testing featured in 48 definitions while clinical signs and radiology featured in 80 and 8 definitions, respectively. DISCUSSION: A diverse range of definitions of neonatal sepsis are used and based on microbiological culture, laboratory tests and clinical signs in contrast to adult and paediatric sepsis which use organ dysfunction. An international consensus-based definition of neonatal sepsis could allow meta-analysis and translate results to improve outcomes.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34743180     DOI: 10.1038/s41390-021-01749-3

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  80 in total

1.  Antibiotic use in early childhood and the development of asthma.

Authors:  K Wickens; N Pearce; J Crane; R Beasley
Journal:  Clin Exp Allergy       Date:  1999-06       Impact factor: 5.018

2.  Outcome of early-onset sepsis in a national cohort of very low birth weight infants.

Authors:  Gil Klinger; Itzhak Levy; Lea Sirota; Valentina Boyko; Liat Lerner-Geva; Brian Reichman
Journal:  Pediatrics       Date:  2010-03-15       Impact factor: 7.124

3.  Antibiotic exposure in early infancy and risk for childhood atopy.

Authors:  Christine Cole Johnson; Dennis R Ownby; Sharon Hensley Alford; Suzanne L Havstad; L Keoki Williams; Edward M Zoratti; Edward L Peterson; Christine L M Joseph
Journal:  J Allergy Clin Immunol       Date:  2005-06       Impact factor: 10.793

4.  Functional impairments at school age of preterm born children with late-onset sepsis.

Authors:  Meike van der Ree; Jozien C Tanis; Koenraad N J A Van Braeckel; Arend F Bos; Elise Roze
Journal:  Early Hum Dev       Date:  2011-07-14       Impact factor: 2.079

5.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

Review 6.  Diagnostics for neonatal sepsis: current approaches and future directions.

Authors:  Pui-Ying Iroh Tam; Catherine M Bendel
Journal:  Pediatr Res       Date:  2017-06-28       Impact factor: 3.756

7.  Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network.

Authors:  Barbara J Stoll; Nellie Hansen; Avroy A Fanaroff; Linda L Wright; Waldemar A Carlo; Richard A Ehrenkranz; James A Lemons; Edward F Donovan; Ann R Stark; Jon E Tyson; William Oh; Charles R Bauer; Sheldon B Korones; Seetha Shankaran; Abbot R Laptook; David K Stevenson; Lu-Ann Papile; W Kenneth Poole
Journal:  Pediatrics       Date:  2002-08       Impact factor: 7.124

8.  Neonatal infection and 5-year neurodevelopmental outcome of very preterm infants.

Authors:  Ayoub Mitha; Laurence Foix-L'Hélias; Catherine Arnaud; Stéphane Marret; Rachel Vieux; Yannick Aujard; Gérard Thiriez; Béatrice Larroque; Gilles Cambonie; Antoine Burguet; Pascal Boileau; Jean Christophe Rozé; Monique Kaminski; Patrick Truffert; Pierre-Yves Ancel
Journal:  Pediatrics       Date:  2013-07-22       Impact factor: 7.124

9.  Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection.

Authors:  Barbara J Stoll; Nellie I Hansen; Ira Adams-Chapman; Avroy A Fanaroff; Susan R Hintz; Betty Vohr; Rosemary D Higgins
Journal:  JAMA       Date:  2004-11-17       Impact factor: 56.272

10.  A neonatal sequential organ failure assessment score predicts mortality to late-onset sepsis in preterm very low birth weight infants.

Authors:  James L Wynn; Richard A Polin
Journal:  Pediatr Res       Date:  2019-08-08       Impact factor: 3.756

View more
  2 in total

Review 1.  Computerized Clinical Decision Support Systems for the Early Detection of Sepsis Among Pediatric, Neonatal, and Maternal Inpatients: Scoping Review.

Authors:  Khalia Ackermann; Jannah Baker; Marino Festa; Brendan McMullan; Johanna Westbrook; Ling Li
Journal:  JMIR Med Inform       Date:  2022-05-06

2.  Procalcitonin levels in preterm newborns: Reference ranges during the first three days of life.

Authors:  Cristina Tuoni; Massimiliano Ciantelli; Riccardo Morganti; Martina Violi; Sara Tamagnini; Luca Filippi
Journal:  Front Pediatr       Date:  2022-08-29       Impact factor: 3.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.